Are you facing Prostate Cancer?

Do you have questions such as “how to cope” and “why me”?

Hopefully, this website can help. You won’t find all of the answers here, but what you will find is the experience of one man, Dr. Bjarne Gabrielsen, who has faced, and continues to face, this challenge for nearly twenty years.

Within the pages of this site, are many current developments in the diagnosis and treatment of prostate cancer, medical resources and updates, spiritual and temporal experiences gained and lessons learned by the writer over a period of nearly twenty years.

Please read on to learn a little more…here is a great place to start.

IMPORTANT ENTRIES IN THE BLOG POSTS;  The most recent posts are dated April 23rd, April 10th, March 20th (osteoporosis)March 19th (psychological effects of hormone treatment), March 9th (imaging), February 19th, February 17th and February 16th. Other recent posts provide advice for newly diagnosed men with prostate cancer (January 23rd), discussed the role of vitamin D in inhibiting prostate cancer growth (January 21st) and MRI/ultrasound-guided biopsies (January 23rd).  An updated Christmas and New Year message was posted on December 23rd.  In addition, a blog recommending a website called prostatesnatchers was also posted on Dec. 23rd. Do you have a condition you’d rather be rid of? See the November 12th post. New guidelines for the treatment of hormone-resistant prostate cancers were posted on September 26th. An expanded use of taxotere in men with metastatic, but hormone-sensitive disease was posted on September 20th.  The Jan. 3rd, 2012 blog post listing prostate cancer drugs either approved or under late stage development is updated as developments are disclosed.  An interesting clinical trial was posted on July 11th, 2012 for men with low-volume prostate cancer. For updated clinical trials information, see the Medical Resources section on this website. E mail subscriptions to these blogs as they are posted is available and your comments to each blog are always welcomed.